Pfizer:
Reframing Sickle Cell Pain

Peer-to-peer education designed to dismantle emergency department misconceptions about sickle cell patients.

Campaign and concept work developed inside MLR and legal review — proof that a process-heavy environment doesn’t have to flatten the idea.

company
Pfizer

role
Creative director · Client management

deliverables
Concept: SCDTruths · Educational platform · Video series · Clinical print advertisements · Point-of-care materials · Medical congress exhibit

agencies
Eveo, frog design (both Capgeini Invent companies)

Challenge:
the audience is the obstacle

Pharma and healthcare creative operates under Medical, Legal, and Regulatory review. Every claim is substantiated, every visual is scrutinized, and the cycle runs long enough that work tends to get more cautious with each pass — until nothing distinctive survives.

The Pfizer sickle cell campaign had the opposite problem: the audience, not the regulator, was the obstacle.

Emergency department physicians held entrenched misconceptions about sickle cell patients — mischaracterizing pain crises as drug-seeking, carrying unconscious bias into treatment decisions, and working from outdated knowledge of sickle cell disease (SCD) management. Those beliefs were a barrier to both patient care and adoption of Pfizer’s new SCD treatment. The campaign had to change minds in a skeptical, time-pressed audience — using voices they would actually trust.

Solution

The strategy was research-first: an insight-discovery phase surfaced the specific misconceptions driving poor care, and everything downstream targeted those root causes rather than symptoms. Because entrenched beliefs don’t yield to brand messaging, credibility had to come from peers — we recruited rare sickle cell disease (SCD) specialists, emergency medicine opinion leaders, and patient advocacy voices, and built the “SCDTruths” video series and educational platform around them.

Working inside MLR shapes the design process itself. My creative partner (creative director, copy) wrote and I built for review: video interviews with those experts, graphics traceable to source, formats that held together through edits, and a site hierarchy with enough give that a reviewer’s addition wouldn’t collapse the layout. Anticipating the review pass was what let the work stay sharp through it.

Campaign

“What’s your Sickle Cell Disease truth?”

As the creative director, visual, I concepted the peer-testimony framework the campaign was built on, then developed it with my creative partner (creative director, copy) and a team of copywriters, art directors, designers, and a medical writer.

The campaign ran across five components: the SCDTruths educational platform, a video series, clinical print advertising, point-of-care materials, and a medical congress exhibit.

Black and white portrait of Dr. Foyekemi Ikyator, wearing glasses, with a red overlay on the right side containing a quote about complications in SCD.

SCD Truths EDUCATIONAL PLATFORM

Co-art directed and co-designed with the art director and visual designers. Copy by the medical writer and medical copywriters.

A digital infographic about Vaso-occlusive crisis, showing human body diagram, blood cell images, and information on symptoms, diagnosis, and complications.
A computer screen displaying a healthcare website titled 'Sickle Cell TRUTHS' and a smartphone showing the same website. The website features a video preview and information about sickle cell disease with a woman in a white coat on the right side of the monitor.
A woman with short, styled hair, wearing a black turtleneck sweater, smiling with earrings and a nose ring, in front of a wooden background.

(per confidentiality, only video stills depicted)

VIDEOS

SCD specialist and key opinion leader (KOL) testimony addressing misconceptions directly, on camera. Scripts by the medical writer; shoot art directed by the medical writer and my creative partner.

Outcome

Clinical trial results ended the program before launch. Pfizer retained the complete campaign strategy and creative assets for future use.

Previous
Previous

Brand evolution: Emergent BioSolutions

Next
Next

Product design: Halliburton